Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00513669
Status:
COMPLETED
Last Update Posted:
2013-03-15
First Post:
2007-08-08
Brief Title:
Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components PEV 301 PEV 302 in Tanzania
Sponsor:
Organization:
Swiss Tropical Public Health Institute